Zelquistinel (GATE-251): Results of a Phase 1 Single Ascending Dose Study to Evaluate the Safety, Pharmacokinetics, and EEG Effects of a Novel Rapid Acting, Orally-Bioavailable NMDA Receptor Modulator
NEUROPSYCHOPHARMACOLOGY（2021）
关键词
Fast-acting Antidepressant, NMDA Glutamate Receptors, Translational Approaches to Drug Development, Synaptic Plasticity
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要